Ojji, PhD, from the University of Abuja in Nigeria, and colleagues compared the effectiveness and safety of a novel low-dose triple-pill protocol with a standard-care protocol for lowering blood ...

HealthDay News — Menopausal hormone therapy (HT) usage rates declined from 2007 to 2023 and remain low, according to a study presented at the annual meeting of The Menopause Society, held from ...

However, omission does result in reductions in neutropenia, thrombocytopenia, and use of granulocyte colony-stimulating factor ...

Users take hearing tests on iPhones or iPads running iOS 18, and then their AirPods make "personalized dynamic adjustments" to allow them to hear.

Veligrotug is an investigational monoclonal antibody that inhibits the activity of insulin-like growth factor-1 receptor.

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to plozasiran for use as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome ...